BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4382059)

  • 21. Effects of antitumor agents and hyperbaric oxygen in normal and tumor-bearing rodents.
    Nathanson L; Brown B; Maddock C; Hall TC
    Cancer; 1966 Jul; 19(7):1019-25. PubMed ID: 4161090
    [No Abstract]   [Full Text] [Related]  

  • 22. Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
    Shepherd R; Harrap KR
    Br J Cancer; 1982 Mar; 45(3):413-20. PubMed ID: 7073935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CANCER CHEMOTHERAPY.
    EISMAN SG; RICHARDSON FM
    Med Sci; 1964 Mar; 15():63-72. PubMed ID: 14143132
    [No Abstract]   [Full Text] [Related]  

  • 24. CYTOTOXIC ACTIVITY COMPARED WITH PHOTOMETRIC MEASUREMENTS OF SELECTED ALKYLATING AGENTS.
    SANDERSON RP; MCKENNA JM; BLAKEMORE WS
    Nature; 1965 Jan; 205():479-81. PubMed ID: 14265292
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative antitumor effects of peptichemio and other alkylating agents.
    Schmid FA; Banks SE; Stock CC
    Cancer Treat Rep; 1977; 61(3):473-5. PubMed ID: 872145
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of azaserine and other growth-inhibiting agents on fetal development of the rat.
    KARNOFSKY DA; MURPHY ML
    Cancer; 1956; 9(5):955-62. PubMed ID: 13364881
    [No Abstract]   [Full Text] [Related]  

  • 27. [MEDICAL THERAPY OF MALIGNANT NEOPLASMS].
    SULLI G
    Clin Ter; 1964 Feb; 28():354-84. PubMed ID: 14138272
    [No Abstract]   [Full Text] [Related]  

  • 28. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
    PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the specificity of anti-proliferative drugs. Comparison of nitrogen mustard, triethylene melamine and cyclophosphamide].
    SCALTRINI GC; TOGNELLA S; CONIGLIARO S; GRIFONI V
    Haematol Lat; 1961; 4():411-22. PubMed ID: 14497771
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of antineoplastic agents on tumor cells in vivo and in vitro (literature review)].
    Merkulov MF; Shelaputina ZF; Leskova SG; Belinskiĭ VA; Talipov ASh
    Farmakol Toksikol; 1971; 34(4):490-504. PubMed ID: 4334362
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of a rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity.
    Schecter RL; Alaoui-Jamali MA; Woo A; Fahl WE; Batist G
    Cancer Res; 1993 Oct; 53(20):4900-6. PubMed ID: 8402679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CHRONIC LEUKEMIA.
    MOLANDER DW; LADUE JS
    Geriatrics; 1964 Jun; 19():393-406. PubMed ID: 14169095
    [No Abstract]   [Full Text] [Related]  

  • 34. Residual marrow injury following cytotoxic drugs.
    Trainor KJ; Seshadri RS; Morley AA
    Leuk Res; 1979; 3(4):205-10. PubMed ID: 533991
    [No Abstract]   [Full Text] [Related]  

  • 35. Concentration and time-dependent inter-relationships for cytotoxicities of nitrogen mustard drugs against lymphoblasts in-vitro.
    Ehrsson H; Wallin I; Ringborg U
    J Pharm Pharmacol; 1988 Dec; 40(12):834-7. PubMed ID: 2907574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitrogen mustard hydrochloride.
    Rep Carcinog; 2004; 11():III192-3. PubMed ID: 21105251
    [No Abstract]   [Full Text] [Related]  

  • 37. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS.
    BOYLAND E; KINDER CH; WILLIAMS K
    Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of the toxic effect of antineoplastic agents].
    Iushkov SF
    Farmakol Toksikol; 1971; 34(1):83-91. PubMed ID: 5570716
    [No Abstract]   [Full Text] [Related]  

  • 39. Unusual toxicities from cancer and immunosuppressive therapy.
    Kahn SB
    Am Fam Physician; 1975 Feb; 11(2):178-9. PubMed ID: 1124712
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison between the hematological side effects of cyclophosphamide and nitrogen mustard.
    NISSEN-MEYER R; HOST H
    Cancer Chemother Rep; 1960 Nov; 9():51-5. PubMed ID: 13729268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.